MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.
Last trade$101.31
Day change-$0.14 (-0.14%)
Day range$100.03 – $103.04
Volume1,540,265
Market cap$63.76B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$63.76B
Price / earnings
18.53×
Price / book
2.32×
Price / sales
0.8×
EV / sales
0.83×
EV / EBITDA
22.91×
Profitability
Earnings per share
$5.48
Return on assets
0.45%
Return on equity
12.54%
Dividend yield
2.64%
Liquidity and leverage
Debt / equity
0.79×
Current ratio
—
Quick ratio
—
Cash ratio
—
Cash flow
Price / cash flow
4.1×
Price / free cash flow
4.1×
Free cash flow
$15.56B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for MET, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$19.15B
$19.07B
$23.81B
$17.36B
$17.34B
$18.57B
$18.67B
$18.44B
Cost of revenue
$11.34B
$11.86B
$16.78B
$10.37B
$10.77B
$11.81B
$12.57B
$10.6B
Gross profit
$7.82B
$7.21B
$7.04B
$6.99B
$6.57B
$6.76B
$6.09B
$7.84B
Selling, general and administrative
$0
$0
$13.86B
$0
$0
$0
$13.02B
$0
Research and development
—
—
—
—
—
—
—
—
Total operating expenses
$18.12B
$17.58B
$22.51B
$16.31B
$16.36B
$17.25B
$17.12B
$16.58B
Operating income
$1.04B
$1.49B
$1.3B
$1.05B
$980M
$1.32B
$1.55B
$1.86B
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
$1.04B
$1.51B
$1.12B
$1.21B
$980M
$1.35B
$1.38B
$1.99B
Income taxes
$256M
$345M
$301M
$308M
$245M
$404M
$106M
$653M
Net income
$779M
$1.16B
$816M
$902M
$735M
$950M
$1.28B
$1.34B
Net income attributable to common shareholders
$705M
$1.14B
$778M
$818M
$698M
$879M
$1.24B
$1.28B
EBITDA
$783M
$1.49B
-$443M
$1.05B
$708M
$1.32B
-$568M
$1.86B
Basic earnings per share
$1.10
$1.75
$1.18
$1.23
$1.04
$1.29
$1.79
$1.82
Diluted earnings per share
$1.09
$1.74
$1.18
$1.22
$1.03
$1.28
$1.78
$1.81
Recent news
Company coverage with links to the original publishers.
Berkshire Hathaway is planning its second yen-denominated bond offering of 2026, leveraging low borrowing costs to fund its growing Japanese investments. The conglomerate's stakes in five major Japanese trading houses have reached $35.4 billion in market value against a $15.4 billion cost basis. By matching yen liabilities with yen assets, Berkshire creates a natural currency hedge while maintaining an average interest rate of 1.2% on its borrowings.
MetLife reported Q3 2026 revenue of $19.91 billion (+11.2% YoY) and EPS of $2.85, beating consensus EPS estimates by 5.17% despite missing revenue estimates by 1.02%. The company showed mixed performance across key metrics, with some AUM figures falling short of analyst expectations while certain revenue segments exceeded estimates. The stock has a Zacks Rank #3 (Hold) rating.
MetLife is projected to report Q3 2026 earnings of $2.71 per share with 15.8% year-over-year growth and revenues of $20.1 billion (+12.4% YoY). The company shows a positive Earnings ESP of +0.59% and Zacks Rank #3, signaling a likely earnings beat. Growth drivers include surging Retirement & Income Solutions revenues (+36.2%) and strong Latin America earnings (+67.8%), though partially offset by declining net investment income (-3.3%) and weaker Asia earnings (-5.2%).
Hippo Holdings (HIPO) reported Q3 earnings of $0.74 per share, significantly beating the consensus estimate of $0.48 and representing a 54.17% earnings surprise. The company also exceeded revenue expectations with $156 million in quarterly revenues. With a Zacks Rank #1 (Strong Buy) rating, the stock is expected to outperform the market in the near term, though the Insurance - Multi line industry remains in the bottom 34% of Zacks-ranked industries.
Five insurance companies—RenaissanceRe, MetLife, Primerica, Ryan Specialty Holdings, and Unum Group—are expected to exceed third-quarter 2026 earnings estimates. The insurance sector is benefiting from prudent pricing, strong policy retention, a benign catastrophe environment, higher interest rates boosting investment income, and digital acceleration. However, pricing pressures and competitive challenges persist across the industry.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Nov 3, 2026
$0.5925
Dec 8, 2026
recurring
Aug 4, 2026
$0.5925
Sep 8, 2026
recurring
May 12, 2026
$0.5925
Jun 9, 2026
recurring
Feb 3, 2026
$0.5675
Mar 10, 2026
recurring
Nov 4, 2025
$0.5675
Dec 9, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.